S Kashiwagi

556 total citations
28 papers, 372 citations indexed

About

S Kashiwagi is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, S Kashiwagi has authored 28 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in S Kashiwagi's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). S Kashiwagi is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). S Kashiwagi collaborates with scholars based in Japan. S Kashiwagi's co-authors include Hideyuki Ikematsu, Jun Hayashi, Yasuhiro Kishihara, Norihiro Furusyo, Yoshitaka Etoh, Masataka Majima, Kouzaburo Yamaji, Kanako Hosono, Taishi Yamamoto and Norio Iwaki and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

S Kashiwagi

25 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Kashiwagi Japan 11 210 127 61 44 42 28 372
José Lorenzo Romero-Trevejo Spain 8 45 0.2× 41 0.3× 116 1.9× 53 1.2× 61 1.5× 18 314
Steffen B. Wiegand Germany 12 314 1.5× 342 2.7× 33 0.5× 37 0.8× 9 0.2× 27 506
Keyla Santos Guedes de Sá Brazil 10 49 0.2× 22 0.2× 98 1.6× 39 0.9× 11 0.3× 18 215
Laura Tarancón‐Díez Spain 11 78 0.4× 34 0.3× 129 2.1× 51 1.2× 25 0.6× 42 388
Zachary R. Barbati United States 6 86 0.4× 41 0.3× 119 2.0× 54 1.2× 95 2.3× 9 330
Xiaofei Yang China 11 90 0.4× 30 0.2× 59 1.0× 108 2.5× 17 0.4× 20 274
Darrenn J. Hart United States 5 92 0.4× 17 0.1× 184 3.0× 43 1.0× 52 1.2× 6 401
MASAHISA SHINGU Japan 9 66 0.3× 12 0.1× 55 0.9× 39 0.9× 12 0.3× 54 300
Tao Bian China 10 149 0.7× 56 0.4× 69 1.1× 102 2.3× 17 0.4× 24 336

Countries citing papers authored by S Kashiwagi

Since Specialization
Citations

This map shows the geographic impact of S Kashiwagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Kashiwagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Kashiwagi more than expected).

Fields of papers citing papers by S Kashiwagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Kashiwagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Kashiwagi. The network helps show where S Kashiwagi may publish in the future.

Co-authorship network of co-authors of S Kashiwagi

This figure shows the co-authorship network connecting the top 25 collaborators of S Kashiwagi. A scholar is included among the top collaborators of S Kashiwagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Kashiwagi. S Kashiwagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baba, Kyoko, et al.. (2021). A patient with macrodystrophia lipomatosa bilaterally affecting the entire upper extremity: reporting of a rare case and literature review. Case Reports in Plastic Surgery and Hand Surgery. 8(1). 1–7. 1 indexed citations
2.
Amano, Hideki, Yoshiya Ito, S Kashiwagi, et al.. (2016). Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model.. Biomedicine & Pharmacotherapy. 78. 140–149. 13 indexed citations
3.
Kashiwagi, S, et al.. (2012). Clinical efficacy of long-acting neuraminidase inhibitor, laninamivir octanoate hydrate, in postmarketing surveillance. International Journal of Infectious Diseases. 16. e88–e88. 1 indexed citations
4.
Kashiwagi, S, Kanako Hosono, Tatsunori Suzuki, et al.. (2011). Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema. Laboratory Investigation. 91(9). 1314–1325. 46 indexed citations
5.
Kashiwagi, S & Chihiro Saitou. (2007). A CASE OF VIPER BITE IN WHICH THE BITTEN FINGER WAS RESCUED BY A RELAXATION INCISION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68(7). 1858–1861.
6.
Kawai, Naoki, Hideyuki Ikematsu, Norio Iwaki, et al.. (2005). Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002--2003 Influenza Season. Clinical Infectious Diseases. 40(9). 1309–1316. 74 indexed citations
7.
Kashiwagi, S, Shoji Kudoh, A. Watanabe, & Isao Yoshimura. (2000). Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir for Prophylaxis against Influenza. Kansenshogaku zasshi. 74(12). 1062–1076. 28 indexed citations
8.
Aso, Yoshio, et al.. (1999). A case of Acquired Immunodeficiency Syndrome (AIDS) with Histoplasmosis. Kansenshogaku zasshi. 73(12). 1227–1231. 1 indexed citations
9.
Hayashi, Jun, Norihiro Furusyo, Yasuhiro Kishihara, et al.. (1998). G Virus in the General Population and in Patients on Hemodialysis. Digestive Diseases and Sciences. 43(9). 2143–2148. 8 indexed citations
10.
Hayashi, Jun, Yasuhiro Kishihara, Kouzaburo Yamaji, et al.. (1997). Hepatitis C Viral Quasispecies and Liver Damage in Patients With Chronic Hepatitis C Virus Infection. Hepatology. 25(3). 697–701. 76 indexed citations
11.
Tanaka, Yasutaka, et al.. (1997). A Case of Hepatocellular Carcinoma Complicated with Psoas Abscess. Kansenshogaku zasshi. 71(2). 175–178.
12.
Yamamoto, T., et al.. (1996). Parvovirus B19 as a trigger for spontaneous bacterial peritonitis in a patient with cirrhotic ascites.. PubMed. 91(9). 1857–9. 2 indexed citations
13.
Kashiwagi, S, et al.. (1995). The neurotrophic pyrimidine heterocyclic compound MS-818 promotes the angiogenesis induced by basic FGF.. PubMed. 15(5-6). 167–74. 10 indexed citations
14.
Maekawa, T, Akira Tateishi, Daikai Sadamitsu, et al.. (1994). Clinical application of mild hypothermia in neurological disorders.. PubMed. 60(10). 537–40. 13 indexed citations
15.
Higashi, Hidefumi, Takashi Matsumata, Katsuhiko Yanaga, et al.. (1994). Detection of hepatitis C virus RNA in the ultrasonic dissector irrigating solution used in liver surgery. British journal of surgery. 81(9). 1346–1347. 4 indexed citations
16.
Higashi, Hidefumi, Takashi Matsumata, Eisuke Adachi, et al.. (1994). Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma. British journal of surgery. 81(9). 1342–1345. 18 indexed citations
17.
Hayashi, Jun, et al.. (1992). Antiviral Effect of Interferon Therapy for Patients with Chronic Hepatitis C. Antiviral chemistry & chemotherapy. 3(5). 305–309. 13 indexed citations
18.
Kashiwagi, S, et al.. (1992). Evaluation of Micro Particle Enzyme Immunoassay (MEIA) for the Demonstration of Antibody to Hepatitis B Surface Antigen. Kansenshogaku zasshi. 66(3). 390–399. 2 indexed citations
19.
Kashiwagi, S, Wataru Kajiyama, Jun Hayashi, et al.. (1990). Antibody to p40tax Protein of Human T Cell Leukemia Virus 1 and Infectivity. The Journal of Infectious Diseases. 161(3). 426–429. 28 indexed citations
20.
Kashiwagi, S, Wataru Kajiyama, Hideyuki Ikematsu, et al.. (1988). Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children. Journal of Infection. 17(1). 49–55. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Lorenzo Romero-Trevejo Breakdown of academic impact, for papers by Steffen B. Wiegand Breakdown of academic impact, for papers by Keyla Santos Guedes de Sá Breakdown of academic impact, for papers by Laura Tarancón‐Díez Breakdown of academic impact, for papers by Zachary R. Barbati Breakdown of academic impact, for papers by Xiaofei Yang Breakdown of academic impact, for papers by Darrenn J. Hart Breakdown of academic impact, for papers by MASAHISA SHINGU Breakdown of academic impact, for papers by Tao Bian
Rankless by CCL
2026